Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 937 to 948 of 955 entries
Sorted by: Best Match Show Resources per page
[Common foundation of alexithymia and expressive suppression].

Psychotherapeut

Schiewer V, Dietz T, Tavenrath S, Öztürk-Arenz H, Jäger RS, Klein A, Labouvie H, Kusch M.
PMID: 34720437
Psychotherapeut (Berl). 2021 Oct 27;1-9. doi: 10.1007/s00278-021-00546-x. Epub 2021 Oct 27.

BACKGROUND: International studies could already prove a correlation between alexithymia and expressive suppression. This relationship has only been marginally considered in the German literature so far. The prioritized aim of the present study was to investigate a correlative and...

Cite
Schiewer V, Dietz T, Tavenrath S, et al. Gemeinsame Grundlage von Alexithymie und expressiver Suppression: Ergebnisse einer empirischen Studie. [Common foundation of alexithymia and expressive suppression]. Psychotherapeut (Berl). 2021;1-9doi: 10.1007/s00278-021-00546-x.
Schiewer, V., Dietz, T., Tavenrath, S., Öztürk-Arenz, H., Jäger, R. S., Klein, A., Labouvie, H., & Kusch, M. (2021). Gemeinsame Grundlage von Alexithymie und expressiver Suppression: Ergebnisse einer empirischen Studie. [Common foundation of alexithymia and expressive suppression]. Psychotherapeut, 1-9. https://doi.org/10.1007/s00278-021-00546-x
Schiewer, Vera, et al. "Gemeinsame Grundlage von Alexithymie und expressiver Suppression: Ergebnisse einer empirischen Studie." [Common foundation of alexithymia and expressive suppression]. Psychotherapeut vol. (2021): 1-9. doi: https://doi.org/10.1007/s00278-021-00546-x
Schiewer V, Dietz T, Tavenrath S, Öztürk-Arenz H, Jäger RS, Klein A, Labouvie H, Kusch M. Gemeinsame Grundlage von Alexithymie und expressiver Suppression: Ergebnisse einer empirischen Studie. [Common foundation of alexithymia and expressive suppression]. Psychotherapeut (Berl). 2021 Oct 27;1-9. doi: 10.1007/s00278-021-00546-x. Epub 2021 Oct 27. German. PMID: 34720437; PMCID: PMC8549590.
Copy Download .nbib Format: NLM
National COVID-19 vaccine program progress and parents' willingness to vaccinate their children.

Human vaccines & immunotherapeutics

Goldman RD, Bone JN, Gelernter R, Krupik D, Ali S, Mater A, Thompson GC, Yen K, Griffiths MA, Klein A, Klein EJ, Mistry RD, Hall JE, Brown JC.
PMID: 34797754
Hum Vaccin Immunother. 2021 Nov 19;1-7. doi: 10.1080/21645515.2021.1999144. Epub 2021 Nov 19.

Vaccinating children against COVID-19 is critical as a public health strategy in order to reach herd immunity and prevent illness among children and adults. The aim of the study was to identify correlation between willingness to vaccinate children under...

Cite
Goldman RD, Bone JN, Gelernter R, et al. National COVID-19 vaccine program progress and parents' willingness to vaccinate their children. Hum Vaccin Immunother. 2021;1-7doi: 10.1080/21645515.2021.1999144.
Goldman, R. D., Bone, J. N., Gelernter, R., Krupik, D., Ali, S., Mater, A., Thompson, G. C., Yen, K., Griffiths, M. A., Klein, A., Klein, E. J., Mistry, R. D., Hall, J. E., & Brown, J. C. (2021). National COVID-19 vaccine program progress and parents' willingness to vaccinate their children. Human vaccines & immunotherapeutics, 1-7. https://doi.org/10.1080/21645515.2021.1999144
Goldman, Ran D, et al. "National COVID-19 vaccine program progress and parents' willingness to vaccinate their children." Human vaccines & immunotherapeutics vol. (2021): 1-7. doi: https://doi.org/10.1080/21645515.2021.1999144
Goldman RD, Bone JN, Gelernter R, Krupik D, Ali S, Mater A, Thompson GC, Yen K, Griffiths MA, Klein A, Klein EJ, Mistry RD, Hall JE, Brown JC. National COVID-19 vaccine program progress and parents' willingness to vaccinate their children. Hum Vaccin Immunother. 2021 Nov 19;1-7. doi: 10.1080/21645515.2021.1999144. Epub 2021 Nov 19. PMID: 34797754.
Copy Download .nbib Format: NLM
Sustainable computational science: the ReScience initiative.

PeerJ. Computer science

Rougier NP, Hinsen K, Alexandre F, Arildsen T, Barba LA, Benureau FCY, Brown CT, de Buyl P, Caglayan O, Davison AP, Delsuc MA, Detorakis G, Diem AK, Drix D, Enel P, Girard B, Guest O, Hall MG, Henriques RN, Hinaut X, Jaron KS, Khamassi M, Klein A, Manninen T, Marchesi P, McGlinn D, Metzner C, Petchey O, Plesser HE, Poisot T, Ram K, Ram Y, Roesch E, Rossant C, Rostami V, Shifman A, Stachelek J, Stimberg M, Stollmeier F, Vaggi F, Viejo G, Vitay J, Vostinar AE, Yurchak R, Zito T.
PMID: 34722870
PeerJ Comput Sci. 2017 Dec 18;3:e142. doi: 10.7717/peerj-cs.142. eCollection 2017.

Computer science offers a large set of tools for prototyping, writing, running, testing, validating, sharing and reproducing results; however, computational science lags behind. In the best case, authors may provide their source code as a compressed archive and they...

Cite
Rougier NP, Hinsen K, Alexandre F, et al. Sustainable computational science: the ReScience initiative. PeerJ Comput Sci. 2017;3:e142doi: 10.7717/peerj-cs.142.
Rougier, N. P., Hinsen, K., Alexandre, F., Arildsen, T., Barba, L. A., Benureau, F. C. Y., Brown, C. T., de Buyl, P., Caglayan, O., Davison, A. P., Delsuc, M. A., Detorakis, G., Diem, A. K., Drix, D., Enel, P., Girard, B., Guest, O., Hall, M. G., Henriques, R. N., Hinaut, X., Jaron, K. S., Khamassi, M., Klein, A., Manninen, T., Marchesi, P., McGlinn, D., Metzner, C., Petchey, O., Plesser, H. E., Poisot, T., Ram, K., Ram, Y., Roesch, E., Rossant, C., Rostami, V., Shifman, A., Stachelek, J., Stimberg, M., Stollmeier, F., Vaggi, F., Viejo, G., Vitay, J., Vostinar, A. E., Yurchak, R., & Zito, T. (2017). Sustainable computational science: the ReScience initiative. PeerJ. Computer science, 3e142. https://doi.org/10.7717/peerj-cs.142
Rougier, Nicolas P, et al. "Sustainable computational science: the ReScience initiative." PeerJ. Computer science vol. 3 (2017): e142. doi: https://doi.org/10.7717/peerj-cs.142
Rougier NP, Hinsen K, Alexandre F, Arildsen T, Barba LA, Benureau FCY, Brown CT, de Buyl P, Caglayan O, Davison AP, Delsuc MA, Detorakis G, Diem AK, Drix D, Enel P, Girard B, Guest O, Hall MG, Henriques RN, Hinaut X, Jaron KS, Khamassi M, Klein A, Manninen T, Marchesi P, McGlinn D, Metzner C, Petchey O, Plesser HE, Poisot T, Ram K, Ram Y, Roesch E, Rossant C, Rostami V, Shifman A, Stachelek J, Stimberg M, Stollmeier F, Vaggi F, Viejo G, Vitay J, Vostinar AE, Yurchak R, Zito T. Sustainable computational science: the ReScience initiative. PeerJ Comput Sci. 2017 Dec 18;3:e142. doi: 10.7717/peerj-cs.142. eCollection 2017. PMID: 34722870; PMCID: PMC8530091.
Copy Download .nbib Format: NLM
GAGrank: Software for Glycosaminoglycan Sequence Ranking Using a Bipartite Graph Model.

Molecular & cellular proteomics : MCP

Hogan JD, Wu J, Klein JA, Lin C, Carvalho L, Zaia J.
PMID: 33992776
Mol Cell Proteomics. 2021;20:100093. doi: 10.1016/j.mcpro.2021.100093. Epub 2021 May 14.

The sulfated glycosaminoglycans (GAGs) are long, linear polysaccharide chains that are typically found as the glycan portion of proteoglycans. These GAGs are characterized by repeating disaccharide units with variable sulfation and acetylation patterns along the chain. GAG length and...

Cite
Hogan JD, Wu J, Klein JA, et al. GAGrank: Software for Glycosaminoglycan Sequence Ranking Using a Bipartite Graph Model. Mol Cell Proteomics. 2021;20:100093doi: 10.1016/j.mcpro.2021.100093.
Hogan, J. D., Wu, J., Klein, J. A., Lin, C., Carvalho, L., & Zaia, J. (2021). GAGrank: Software for Glycosaminoglycan Sequence Ranking Using a Bipartite Graph Model. Molecular & cellular proteomics : MCP, 20100093. https://doi.org/10.1016/j.mcpro.2021.100093
Hogan, John D, et al. "GAGrank: Software for Glycosaminoglycan Sequence Ranking Using a Bipartite Graph Model." Molecular & cellular proteomics : MCP vol. 20 (2021): 100093. doi: https://doi.org/10.1016/j.mcpro.2021.100093
Hogan JD, Wu J, Klein JA, Lin C, Carvalho L, Zaia J. GAGrank: Software for Glycosaminoglycan Sequence Ranking Using a Bipartite Graph Model. Mol Cell Proteomics. 2021;20:100093. doi: 10.1016/j.mcpro.2021.100093. Epub 2021 May 14. PMID: 33992776; PMCID: PMC8214146.
Copy Download .nbib Format: NLM
Extensive NEUROG3 occupancy in the human pancreatic endocrine gene regulatory network.

Molecular metabolism

Schreiber V, Mercier R, Jiménez S, Ye T, García-Sánchez E, Klein A, Meunier A, Ghimire S, Birck C, Jost B, de Lichtenberg KH, Honoré C, Serup P, Gradwohl G.
PMID: 34352411
Mol Metab. 2021 Nov;53:101313. doi: 10.1016/j.molmet.2021.101313. Epub 2021 Aug 03.

OBJECTIVE: Mice lacking the bHLH transcription factor (TF) Neurog3 do not form pancreatic islet cells, including insulin-secreting beta cells, the absence of which leads to diabetes. In humans, homozygous mutations of NEUROG3 manifest with neonatal or childhood diabetes. Despite...

Cite
Schreiber V, Mercier R, Jiménez S, et al. Extensive NEUROG3 occupancy in the human pancreatic endocrine gene regulatory network. Mol Metab. 2021;53:101313doi: 10.1016/j.molmet.2021.101313.
Schreiber, V., Mercier, R., Jiménez, S., Ye, T., García-Sánchez, E., Klein, A., Meunier, A., Ghimire, S., Birck, C., Jost, B., de Lichtenberg, K. H., Honoré, C., Serup, P., & Gradwohl, G. (2021). Extensive NEUROG3 occupancy in the human pancreatic endocrine gene regulatory network. Molecular metabolism, 53101313. https://doi.org/10.1016/j.molmet.2021.101313
Schreiber, Valérie, et al. "Extensive NEUROG3 occupancy in the human pancreatic endocrine gene regulatory network." Molecular metabolism vol. 53 (2021): 101313. doi: https://doi.org/10.1016/j.molmet.2021.101313
Schreiber V, Mercier R, Jiménez S, Ye T, García-Sánchez E, Klein A, Meunier A, Ghimire S, Birck C, Jost B, de Lichtenberg KH, Honoré C, Serup P, Gradwohl G. Extensive NEUROG3 occupancy in the human pancreatic endocrine gene regulatory network. Mol Metab. 2021 Nov;53:101313. doi: 10.1016/j.molmet.2021.101313. Epub 2021 Aug 03. PMID: 34352411; PMCID: PMC8387919.
Copy Download .nbib Format: NLM
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice.

Cancers

Nadauld LD, McDonnell CH, Beer TM, Liu MC, Klein EA, Hudnut A, Whittington RA, Taylor B, Oxnard GR, Lipson J, Lopatin M, Shaknovich R, Chung KC, Fung ET, Schrag D, Marinac CR.
PMID: 34298717
Cancers (Basel). 2021 Jul 13;13(14). doi: 10.3390/cancers13143501.

To examine the extent of the evaluation required to achieve diagnostic resolution and the test performance characteristics of a targeted methylation cell-free DNA (cfDNA)-based multi-cancer early detection (MCED) test, ~6200 participants ≥50 years with (cohort A) or without (cohort...

Cite
Nadauld LD, McDonnell CH, Beer TM, et al. The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. Cancers (Basel). 2021;13(14)doi: 10.3390/cancers13143501.
Nadauld, L. D., McDonnell, C. H., Beer, T. M., Liu, M. C., Klein, E. A., Hudnut, A., Whittington, R. A., Taylor, B., Oxnard, G. R., Lipson, J., Lopatin, M., Shaknovich, R., Chung, K. C., Fung, E. T., Schrag, D., & Marinac, C. R. (2021). The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. Cancers, 13(14), . https://doi.org/10.3390/cancers13143501
Nadauld, Lincoln D, et al. "The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice." Cancers vol. 13,14 (2021). doi: https://doi.org/10.3390/cancers13143501
Nadauld LD, McDonnell CH, Beer TM, Liu MC, Klein EA, Hudnut A, Whittington RA, Taylor B, Oxnard GR, Lipson J, Lopatin M, Shaknovich R, Chung KC, Fung ET, Schrag D, Marinac CR. The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. Cancers (Basel). 2021 Jul 13;13(14). doi: 10.3390/cancers13143501. PMID: 34298717; PMCID: PMC8304888.
Copy Download .nbib Format: NLM
Prosociality from the perspective of environmental psychology.

Current opinion in psychology

Klein SA, Nockur L, Reese G.
PMID: 34695642
Curr Opin Psychol. 2021 Sep 22;44:182-187. doi: 10.1016/j.copsyc.2021.09.001. Epub 2021 Sep 22.

Pro-environmental behavior, a form of prosocial behavior that ultimately benefits all humanity, is essential for addressing climate change. This review presents pro-environmental behavior in a social dilemma framework describing how non-aligned interests in nested groups (e.g. smaller groups with...

Cite
Klein SA, Nockur L, Reese G. Prosociality from the perspective of environmental psychology. Curr Opin Psychol. 2021;44:182-187doi: 10.1016/j.copsyc.2021.09.001.
Klein, S. A., Nockur, L., & Reese, G. (2021). Prosociality from the perspective of environmental psychology. Current opinion in psychology, 44182-187. https://doi.org/10.1016/j.copsyc.2021.09.001
Klein, Sina A, et al. "Prosociality from the perspective of environmental psychology." Current opinion in psychology vol. 44 (2021): 182-187. doi: https://doi.org/10.1016/j.copsyc.2021.09.001
Klein SA, Nockur L, Reese G. Prosociality from the perspective of environmental psychology. Curr Opin Psychol. 2021 Sep 22;44:182-187. doi: 10.1016/j.copsyc.2021.09.001. Epub 2021 Sep 22. PMID: 34695642.
Copy Download .nbib Format: NLM
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.

Clinical cancer research : an official journal of the American Association for Cancer Research

Chen X, Dong Z, Hubbell E, Kurtzman KN, Oxnard GR, Venn O, Melton C, Clarke CA, Shaknovich R, Ma T, Meixiong G, Seiden MV, Klein EA, Fung ET, Liu MC.
PMID: 34088722
Clin Cancer Res. 2021 Aug 01;27(15):4221-4229. doi: 10.1158/1078-0432.CCR-21-0417. Epub 2021 Jun 04.

PURPOSE: We recently reported the development of a cell-free DNA (cfDNA) targeted methylation (TM)-based sequencing approach for a multi-cancer early detection (MCED) test that includes cancer signal origin prediction. Here, we evaluated the prognostic significance of cancer detection by...

Cite
Chen X, Dong Z, Hubbell E, et al. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA. Clin Cancer Res. 2021;27(15):4221-4229doi: 10.1158/1078-0432.CCR-21-0417.
Chen, X., Dong, Z., Hubbell, E., Kurtzman, K. N., Oxnard, G. R., Venn, O., Melton, C., Clarke, C. A., Shaknovich, R., Ma, T., Meixiong, G., Seiden, M. V., Klein, E. A., Fung, E. T., & Liu, M. C. (2021). Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(15), 4221-4229. https://doi.org/10.1158/1078-0432.CCR-21-0417
Chen, Xiaoji, et al. "Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,15 (2021): 4221-4229. doi: https://doi.org/10.1158/1078-0432.CCR-21-0417
Chen X, Dong Z, Hubbell E, Kurtzman KN, Oxnard GR, Venn O, Melton C, Clarke CA, Shaknovich R, Ma T, Meixiong G, Seiden MV, Klein EA, Fung ET, Liu MC. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA. Clin Cancer Res. 2021 Aug 01;27(15):4221-4229. doi: 10.1158/1078-0432.CCR-21-0417. Epub 2021 Jun 04. PMID: 34088722.
Copy Download .nbib Format: NLM
A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Gupta M, Kaul S, Velazquez GR, Bandyopadhyay D, Fonarow GC, Klein A, Ghosh RK.
PMID: 34008144
Am J Cardiovasc Drugs. 2022 Jan;22(1):27-33. doi: 10.1007/s40256-021-00481-x. Epub 2021 May 19.

Recurrent pericarditis affects 15-30% of patients after acute pericarditis. A large number of the patients with recurrent pericarditis can become corticosteroid dependent, leading to disease chronicity and drug dependence, with additional morbidity from long-term steroid use. Recent randomized trials...

Cite
Gupta M, Kaul S, Velazquez GR, et al. A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option. Am J Cardiovasc Drugs. 2021;22(1):27-33doi: 10.1007/s40256-021-00481-x.
Gupta, M., Kaul, S., Velazquez, G. R., Bandyopadhyay, D., Fonarow, G. C., Klein, A., & Ghosh, R. K. (2022). A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option. American journal of cardiovascular drugs : drugs, devices, and other interventions, 22(1), 27-33. https://doi.org/10.1007/s40256-021-00481-x
Gupta, Manasvi, et al. "A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option." American journal of cardiovascular drugs : drugs, devices, and other interventions vol. 22,1 (2022): 27-33. doi: https://doi.org/10.1007/s40256-021-00481-x
Gupta M, Kaul S, Velazquez GR, Bandyopadhyay D, Fonarow GC, Klein A, Ghosh RK. A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option. Am J Cardiovasc Drugs. 2022 Jan;22(1):27-33. doi: 10.1007/s40256-021-00481-x. Epub 2021 May 19. PMID: 34008144.
Copy Download .nbib Format: NLM
Relative Sensitivity of Core-Needle Biopsy and Incisional Biopsy in the Diagnosis of Musculoskeletal Sarcomas.

Cancers

Klein A, Fell T, Birkenmaier C, Fromm J, Jansson V, Knösel T, Dürr HR.
PMID: 33808591
Cancers (Basel). 2021 Mar 19;13(6). doi: 10.3390/cancers13061393.

BACKGROUND: There is no evidence as to the diagnostic value of the two most frequently used methods of biopsies in sarcomas: Incisional or core needle biopsy. The aim of our study was to evaluate the diagnostic sensitivity of the...

Cite
Klein A, Fell T, Birkenmaier C, et al. Relative Sensitivity of Core-Needle Biopsy and Incisional Biopsy in the Diagnosis of Musculoskeletal Sarcomas. Cancers (Basel). 2021;13(6)doi: 10.3390/cancers13061393.
Klein, A., Fell, T., Birkenmaier, C., Fromm, J., Jansson, V., Knösel, T., & Dürr, H. R. (2021). Relative Sensitivity of Core-Needle Biopsy and Incisional Biopsy in the Diagnosis of Musculoskeletal Sarcomas. Cancers, 13(6), . https://doi.org/10.3390/cancers13061393
Klein, Alexander, et al. "Relative Sensitivity of Core-Needle Biopsy and Incisional Biopsy in the Diagnosis of Musculoskeletal Sarcomas." Cancers vol. 13,6 (2021). doi: https://doi.org/10.3390/cancers13061393
Klein A, Fell T, Birkenmaier C, Fromm J, Jansson V, Knösel T, Dürr HR. Relative Sensitivity of Core-Needle Biopsy and Incisional Biopsy in the Diagnosis of Musculoskeletal Sarcomas. Cancers (Basel). 2021 Mar 19;13(6). doi: 10.3390/cancers13061393. PMID: 33808591; PMCID: PMC8003555.
Copy Download .nbib Format: NLM
Photoluminescence of Ni(II), Pd(II), and Pt(II) Complexes [M(Me.

Molecules (Basel, Switzerland)

Kletsch L, Jordan R, Köcher AS, Buss S, Strassert CA, Klein A.
PMID: 34443649
Molecules. 2021 Aug 20;26(16). doi: 10.3390/molecules26165051.

The three complexes [M(Me

Cite
Kletsch L, Jordan R, Köcher AS, et al. Photoluminescence of Ni(II), Pd(II), and Pt(II) Complexes [M(Me. Molecules. 2021;26(16)doi: 10.3390/molecules26165051.
Kletsch, L., Jordan, R., Köcher, A. S., Buss, S., Strassert, C. A., & Klein, A. (2021). Photoluminescence of Ni(II), Pd(II), and Pt(II) Complexes [M(Me. Molecules (Basel, Switzerland), 26(16), . https://doi.org/10.3390/molecules26165051
Kletsch, Lukas, et al. "Photoluminescence of Ni(II), Pd(II), and Pt(II) Complexes [M(Me." Molecules (Basel, Switzerland) vol. 26,16 (2021). doi: https://doi.org/10.3390/molecules26165051
Kletsch L, Jordan R, Köcher AS, Buss S, Strassert CA, Klein A. Photoluminescence of Ni(II), Pd(II), and Pt(II) Complexes [M(Me. Molecules. 2021 Aug 20;26(16). doi: 10.3390/molecules26165051. PMID: 34443649; PMCID: PMC8401505.
Copy Download .nbib Format: NLM
[No title available]

Journal of biomolecular structure & dynamics

Adekiya TA, Aruleba RT, Klein A, Fadaka AO.
PMID: 33225839
J Biomol Struct Dyn. 2020 Nov 23;1-9. doi: 10.1080/07391102.2020.1850363. Epub 2020 Nov 23.

Schistosomiasis is an infectious tropical disease caused by parasitic flatworm of the genus Schistosoma. This debilitating disease chronically infects about 200 million people globally and management relies on chemotherapy. Unfortunately, the solely available schistosomicide (praziquantel) against all forms of...

Cite
Adekiya TA, Aruleba RT, Klein A, et al. . J Biomol Struct Dyn. 2020;1-9doi: 10.1080/07391102.2020.1850363.
Adekiya, T. A., Aruleba, R. T., Klein, A., & Fadaka, A. O. (2020). . Journal of biomolecular structure & dynamics, 1-9. https://doi.org/10.1080/07391102.2020.1850363
Adekiya, Tayo A, et al. "." Journal of biomolecular structure & dynamics vol. (2020): 1-9. doi: https://doi.org/10.1080/07391102.2020.1850363
Adekiya TA, Aruleba RT, Klein A, Fadaka AO. . J Biomol Struct Dyn. 2020 Nov 23;1-9. doi: 10.1080/07391102.2020.1850363. Epub 2020 Nov 23. PMID: 33225839.
Copy Download .nbib Format: NLM
Showing 937 to 948 of 955 entries